Best Brad Hightower Podcasts (2025)

1
Digital Health, Clinical Trials, and Beyond with Matthew Holt - The Health Care Blog 54:11

1h ago54:11

54:11

In this episode we sit down with healthcare veteran Matthew Holt, founder of The Health Care Blog and Health 2.0. Matthew shares his fascinating journey from Stanford grad student to healthcare technology commentator, offering candid insights into digital health, clinical trials, and the challenges of healthcare innovation. From discussing the pote…

1
Clinical Research Confessions: PE, Trials, and Research Sins 30:21

18m ago30:21

30:21

In this episode of Note to File, we dive deep into the world of clinical research, exploring the challenges of resident physician training, the impact of private equity on clinical trial management systems, and the often-unspoken ethical dilemmas in the field. Join us as we unpack difficult sponsor behaviors, share hilarious research confessions, a…

1
Clinical Trials 2.0: AI, Predictions, and the Future of Research with Lokavant 48:59

5d ago48:59

48:59

Special Pope election edition. In this episode, Rohit Nambisan from Lokavant and Jonathan Crowther from Pfizer discuss their innovative approach to clinical trial forecasting. They explore how advanced data analytics and AI can help predict and improve trial operational success, from site selection to protocol design. The conversation delves into r…

1
CROs are Broken: Fixing Clinical Trials from the Inside Out with Meri Beckwith - Lindus Health 50:03

5d ago50:03

50:03

In this episode, Meri Beckwith from Lindus Health discusses his journey from venture capital to clinical research, sharing insights on the inefficiencies of traditional CROs. He explains how Lindus is taking a different approach by aligning incentives, focusing on patient experience, and developing innovative trial models. The conversation explores…

1
Sticky Notes 4/30/25 35:29

8d ago35:29

35:29

In this episode of Sticky Notes, Brad & Denali dive into the latest trends in clinical research, exploring how younger adults are getting medical advice from social media, the potential impact of pharmaceutical tariffs on R&D, and the evolving landscape of decentralized clinical trials. We discuss the challenges and opportunities of involving healt…

1
Bree Burks - Veeva 45:57

15d ago45:57

45:57

We sit down with Bree Burks from Veeva to discuss the company's latest innovations in clinical research technology. We dive deep into Veeva's upcoming CTMS (Clinical Trial Management System), their strategy for connecting sponsors and sites, and the importance of creating more streamlined, user-friendly technology for clinical research sites. Bree …

1
Sticky Notes 4/15/2025 30:32

22d ago30:32

30:32

In this episode, Brad and Denali dive into recent industry developments, including Bay Pine's $1.5 billion acquisition of CenExel clinical research site network, the FDA's potential shift to AI-based animal testing alternatives, growing challenges with clinical trial recruitment and public trust, emerging pharmaceutical import tariffs, and the ongo…

1
CAIS’s Brad Walker on Making Alternative Investments Accessible 28:38

24d ago28:38

28:38

Join David Bodamer, Editorial Director at WealthManagement.com, and his guest, Brad Walker, Co-President at CAIS, as they delve into the transformative landscape of alternative investments. Discover why independent wealth managers and RIAs are increasingly incorporating alts into client portfolios and the innovative trends making this possible. Hig…

1
Jim Kremidas - AMRC 52:55

29d ago52:55

52:55

In this episode Jim Kremidas, Executive Director of the Association of Multi-Site Research Corporations (AMRC), discusses the evolving landscape of clinical research sites. We explore how multi-site research corporations are working to improve operational efficiency, quality standards, and patient experiences in clinical trials. Kremidas shares ins…

1
From The Archives: Jamie Massengill - SSM Health 1:02:43

1M ago1:02:43

1:02:43

In this episode, we sit down with Jamie Massengill from SSM Health to unpack the complex world of clinical research in community healthcare. We dive deep into the challenges of launching successful research programs, exploring innovative partnership models, physician engagement strategies, and how community hospitals can transform clinical trials. …

1
Chris Venezia - ProofPilot 50:39

2M ago50:39

50:39

In this episode we talk with Chris Venezia, CEO of ProofPilot, about the often-overlooked operational challenges in clinical trials. Chris shares his unexpected journey into clinical research and reveals how ProofPilot is transforming the industry by simplifying communication, document sharing, and patient engagement. From addressing fundamental co…

1
Tyler Van Horn - Science 37 55:33

2M ago55:33

55:33

We talk to Science 37 CEO Tyler Van Horn and discuss the past, present and future of the company - everything you wanted to know about Science 37 but were afraid to ask.

1
Sticky Notes 3/19/2025 54:34

2M ago54:34

54:34

This episode is dedicated to feedback about the recent Save Our Sites (SOS) conference in Oklahoma City. The founders, Judy Galindo, Ashley Margot, Chris Sauber, Monica Cultiva and Dan Sfera join as we take live feedback from the livestream audience.

1
Sticky Notes 3/12/2025 31:25

2M ago31:25

31:25

A short recap of recent news, events, social media posts, gossip, announcements, and anything else in the clinical research space. In this episode Paul Ivsin joins to talk Science 37 v Science 38, PEs buyout of Walgreens and CRA/CRC relationships.

1
Wealth Management Invest: Apollo’s Stephanie Drescher on Bringing Alts to the Wealth Channel 31:43

2M ago31:43

31:43

Join David Bodamer as he sits down with Stephanie Drescher, Apollo’s chief client and product development officer, to unravel the potential of alternative investments for wealth advisors. David and Stephanie explore why Apollo is confident in hitting $150 billion in assets within the wealth channel and why traditional portfolios fall short without …

1
Denise Bronner PhD - Empactful Ventures 53:17

2M ago53:17

53:17

Today we discuss vendor relationships , representation & its impact on business, diagnosis & after care - the main unmet need within pharma - and embroidery throwing.

1
Sticky Notes 2/26/2025 26:00

3M ago26:00

26:00

In this episode Dan Sfera joins us to cover the somewhat puzzling creation of the Association for Multisite Corporations (AMRC), a big time data breach from DM Clinical Research, and why everything in clinical research is an emergency.

1
Wealth Management Invest: Unpacking Hightower’s Approach to Private Markets with Robert Picard 35:14

3M ago35:14

35:14

In this episode of the Wealth Management Invest Podcast, host David Bodamer sits down with Robert Picard, managing director and head of alternative investments at Hightower, to unravel the shifting dynamics of private markets and their role in contemporary investment portfolios. With over 34 years of experience, Robert shares insights into why bill…

1
Paul Ivsin 53:00

3M ago53:00

53:00

In this episode we discuss the challenges and perceptions of central recruitment campaigns, including resistance from sites, the need for a thoughtful, patient-centered approaches rather than a boiler room approach and Paul helps to dispell a few clinical trial myths.By Note to File: A Clinical Research Podcast

1
Wealth Management Invest: Ares’ Approach to Private Markets with Brendan McCurdy 27:25

3M ago27:25

27:25

In this episode of the Wealth Management Invest podcast, host David Bodamer connects with Brendan McCurdy, managing director and co-head of the financial advisor solutions team at Ares, to delve into private market investments. They discuss how financial advisors navigate the complexities of private equity, private credit, real estate, and infrastr…

1
Wealth Management INVEST: A Global Perspective on Wealth Investment in Private Markets with Partners Group’s Robert Collins 29:09

5M ago29:09

29:09

WealthManagement.com’s Executive Editor for Investments David Bodamer chats with Robert Collins, co-head of private wealth at Partners Group. Partners Group, an alternative asset manager, was an early mover into the global wealth market, including a popular 15-year-old private equity fund in the United States. Collins explores the shift from public…

1
Wealth Management Invest: Brookfield’s David Levi on HNW Investors’ Views on Alternatives 28:24

6M ago28:24

28:24

WealthManagement.com’s David Bodamer delves into the recent research published by Brookfield Oaktree Wealth Solutions with David Levi, managing partner and CEO of Brookfield’s Global Client Group. During their conversation, they discuss Brookfield’s strategic focus on making institutional-quality assets accessible to a broader investor base. David …

1
Wealth Management Invest: Breaking Down Semi-Liquid Funds with StepStone’s Bob Long 28:32

7M ago28:32

28:32

In this episode of the Wealth Management Invest podcast, host David Bodamer sits down with Bob Long, CEO and partner of StepStone Private Wealth, to explore StepStone’s approach to developing private market investments for the wealth channel. Long discusses why Stepstone has opted for evergreen funds—semi-liquid, continuously invested structures ra…

1
Wealth Management INVEST: Trends in Advisor Portfolio Construction 25:58

8M ago25:58

25:58

David Bodamer of WealthManagement.com sits down with Mike Scarsciotti, SVP and Head of Investment Specialists at Fidelity Investments, to discuss the changing dynamics of portfolio construction. Fidelity draws insights from analyzing 12,000 portfolios. Their conversation covers significant trends, including the growing popularity of ETFs, the resur…

1
Wealth Management INVEST: Private Market Insights with Blackstone’s Joan Solotar 31:37

8M ago31:37

31:37

David Bodamer sits down with Joan Solotar, Global Head of Private Wealth Solutions at Blackstone, to explore the evolution of private market investments and how financial advisors can leverage these opportunities to enhance their clients’ portfolios. Joan discusses how technology and innovation are reshaping investment processes, making it easier f…

1
Wealth Management INVEST: Assessing Active ETFs, Live from the Morningstar Investor Conference with Jack Shannon 43:28

10M ago43:28

43:28

David Bodamer speaks with Jack Shannon, a senior analyst on Morningstar’s manager research team, in an episode recorded in front of a live audience at the Morningstar Investor Conference. They delve into the distinctions between active and passive ETFs, highlighting the nuances in their management and trading and whether active ETFs deliver on thei…

1
Wealth Management INVEST: Investing in Private Markets with a Fiduciary-First Approach 29:37

11M ago29:37

29:37

WealthManagement.com’s David Bodamer speaks with Jake Miller, Co-Founder and Chief Solutions Officer at Opto Investments, about the evolving landscape of private markets and how RIAs can leverage new strategies to benefit their clients. They touch on the opportunities and challenges within private equity, private credit, infrastructure, and real es…

1
Wealth Management INVEST: Wealth Enhancement Group’s Approach to Private Investments 26:52

12M ago26:52

26:52

WealthManagement.com’s David Bodamer sits down with Doug Huber, Vice President of Investment Strategy at Wealth Enhancement Group, to delve into how the RIA approaches private market strategies amid the ongoing evolution of alternative investments. Doug focuses on: What is the trend of democratization in alternative investments and increased invest…

1
WealthManagement INVEST: Bridging the Gap in Fixed Income Opportunities 24:51

1y ago24:51

24:51

Listen in as David Bodamer sits down with Karen Veraa, Head of iShares US Fixed Income Strategy, to discuss fixed-income ETFs. Karen shares insight on navigating the current market complexities, from managing inflation impacts to exploring strategic investment avenues. Karen focuses on: The current state and future prospects of fixed-income markets…

1
WealthManagement INVEST: Trends and Innovations in Alternative Investments 30:58

1y ago30:58

30:58

Listen in as David Bodamer sits down with Lawrence Calcano, Chairman and CEO of iCapital, to explore the world of alternative investments and their role in modern portfolio strategies. They unravel the complexities of the alt space, examine recent developments at iCapital, and discuss how advisors are integrating these assets into their offerings f…

1
Wealth Management INVEST: Exploring Private Market Strategies with Tony Davidow 26:05

1y ago26:05

26:05

WealthManagement.com’s David Bodamer is joined by Tony Davidow, Senior Alternatives Investment Strategist with Franklin Templeton Institute. With over 35 years in the industry, Tony shares insights on the increasing accessibility of alternative strategies and the role of private credit, private equity, and real estate in diversified portfolios. He …

1
Wealth Management INVEST: How Can Alternative Investments Benefit Portfolios 21:16

1y ago21:16

21:16

WealthManagement.com’s David Bodamer sits down with Aaron Filbeck, who leads UniFi by CAIA, to delve into how the CAIA association contributes to the education surrounding alternative investments. They explore the recent overhaul of the CAIA’s core program, designed to equip industry experts with a thorough grasp of alternative investment approache…

1
Wealth Management INVEST: How Private Markets Are Becoming More Accessible 25:28

1+ y ago25:28

25:28

Innovations in product development have increased access to private markets for financial advisors and their clients. Steve Brennan, managing director and head of Private Wealth Solutions at Hamilton Lane, joined David Bodamer to discuss the state of private investments and Hamilton Lane’s path to developing private wealth strategies. Steve focuses…

1
REPLAY! WMRE Common Area: Exploring Tax-Advantaged Real Estate Options with Louis Rogers 38:34

1+ y ago38:34

38:34

Some real estate structures offer investors major tax benefits. Like-kind exchanges allow investors to roll capital gains from one real estate investment into a new one. DSTs allow 1031 exchangers to pool capital into a fund. Qualified Opportunity Zone funds allow investors to defer capital gains from any previous investments. In this episode, Davi…

Podcasts Worth a Listen

Brad Hightower Podcasts

Podcasts Worth a Listen